FDA-approved Monotherapies
FDA-approved Combination Therapies
Intron A
Roferon

Infergen
Pegasys
PEG-Intron
Pegasys + Copegus
PEG-Intron + Rebetol
Intron A + Rebetol
Roferon A + Ribavirin

Coffee Consumption May Reduce the Risk of Liver Cancer

By Liz Highleyman

Several studies released over the past several years have added to the evidence that coffee may have a beneficial effect on the liver.

As reported in the August 2007 issue of Hepatology, Italian researchers performed a meta-analysis of epidemiologic studies to quantitatively assess the relation between coffee consumption and the risk of liver cancer.

Relevant studies were identified by searching MEDLINE from 1966 through February 2007, and going through the reference lists of retrieved articles. The researchers included cohort and case-control studies that reported relative risk estimates with 95% confidence intervals of primary liver cancer or hepatocellular carcinoma (HCC) by quantitative categories of coffee consumption.

Results

4 cohort studies (from Japan) and 5 case-control studies (from southern Europe and Japan) met the inclusion criteria.

Altogether, these studies involved 2260 cases (patients with liver cancer) and 239,146 non-cases (control subjects).

All studies observed an inverse relation between coffee consumption and risk of liver cancer, indicating that coffee has a protective effect.

In 6 studies, the association was statistically significant.

Overall, an increase in consumption of 2 cups of coffee per day was associated with a 43% reduction in the risk of liver cancer (RR 0.57; 95% CI 0.49-0.67).

The reduction in risk was greater (55%) for heavy coffee drinkers, and less (30%) for low-to-moderate coffee consumers.

In a stratified analysis, the summary relative risks of liver cancer for an increase in consumption of 2 cups of coffee per day were 0.69 (95% CI 0.55-0.87) for people without a history of liver disease and 0.56 (95% CI 0.35-0.91) for those with past liver disease.

The association between coffee consumption and liver cancer risk remained even after adjusted for potentially confounding factors including liver cirrhosis, hepatitis B and C, social class, alcohol intake, and smoking status.

Conclusion

In conclusion, the authors wrote, "Findings from this meta-analysis suggest that an increased consumption of coffee may reduce the risk of liver cancer."

However, they cautioned, "The present analysis provides evidence that the inverse relation between coffee and HCC is real, though inference on causality remains open to discussion."

It is unclear why coffee consumption is associated with lower risk of liver cancer, but it may be related to coffee's protective effect with regard to fibrosis and cirrhosis.

Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy; Dipartimento di Statistica, Università degli Studi di Milano-Bicocca, Milan, Italy; International Agency for Research on Cancer, Lyon, France; Istituto di Statistica Medica e Biometria, Università degli Studi di Milano, Milan, Italy.

08/31/07

Reference
F Bravi, C Bosetti, A Tavani, and others. Coffee Drinking and Hepatocellular Carcinoma Risk: A Meta-Analysis. Hepatology 46(2): 430435. August 2007.


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 





Google_______________